CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
     
Stemline Therapeutics Inc  (STML)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

EARNINGS REPORT by CSIMarket

Company Fail to Break-even Despite Surge in Sales


decrease font size NEWS BETA Increase font size

Stemline Therapeutics Inc announced first quarter 2017 operating loss of $-14.688698 millions



Company increased losses at $-0.67 per share in the first quarter 2017, although it's Sales surged to $0 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $0 millions and $-0.56 per share.

For the first quarter 2017 Stemline Therapeutics Inc realized net loss of $-15 million, bigger than $-9 million a year ago.
Stocks
Economy
Industries
Other STML's Earnings Reports

Stemline Therapeutics Inc reported forth quarter 2016 earnings

Stemline Therapeutics Inc reported third quarter 2016 earnings

Stemline Therapeutics Inc reported second quarter 2016 earnings



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com